Microstructural alterations in different types of lesions and their perilesional white matter in relapsing-remitting multiple sclerosis based on diffusion kurtosis imaging.

[1]  A. Gass,et al.  Exploring (peri-) lesional and structural connectivity tissue damage through T1/T2-weighted ratio in iron rim multiple sclerosis lesions. , 2022, Magnetic resonance imaging.

[2]  Yongmei Li,et al.  The heterogeneity of tissue destruction between iron rim lesions and non-iron rim lesions in multiple sclerosis: A diffusion MRI study. , 2022, Multiple sclerosis and related disorders.

[3]  Yongmei Li,et al.  The Application of Diffusion Kurtosis Imaging on the Heterogeneous White Matter in Relapsing-Remitting Multiple Sclerosis , 2022, Frontiers in Neuroscience.

[4]  D. Reich,et al.  Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical outcomes in multiple sclerosis: a retrospective cross-sectional study , 2022, medRxiv.

[5]  Hongyan Ni,et al.  Microstructural white matter alterations in Alzheimer’s disease and amnestic mild cognitive impairment and its diagnostic value based on diffusion kurtosis imaging: a tract-based spatial statistics study , 2021, Brain Imaging and Behavior.

[6]  F. Paul,et al.  Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation , 2021, Multiple sclerosis.

[7]  S. Jespersen,et al.  Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging , 2021, PloS one.

[8]  G. Kasprian,et al.  Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI. , 2021, Brain : a journal of neurology.

[9]  José P. Marques,et al.  SEPIA—Susceptibility mapping pipeline tool for phase images , 2020, NeuroImage.

[10]  D. Reich,et al.  Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo. , 2019, JAMA neurology.

[11]  S. Zhang,et al.  Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions , 2019, American Journal of Neuroradiology.

[12]  A. Håberg,et al.  Diffusion kurtosis imaging in mild traumatic brain injury and postconcussional syndrome , 2019, Journal of neuroscience research.

[13]  David Pitt,et al.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions , 2018, Brain : a journal of neurology.

[14]  J. Hsu,et al.  Diffusion kurtosis imaging as a neuroimaging biomarker in patients with carbon monoxide intoxication , 2018, Neurotoxicology.

[15]  B. Yin,et al.  Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging , 2018, BMC Neurology.

[16]  F. Barkhof,et al.  Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study , 2018, Brain : a journal of neurology.

[17]  R. Parkkola,et al.  Microglial activation, white matter tract damage, and disability in MS , 2018, Neurology: Neuroimmunology & Neuroinflammation.

[18]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[19]  S. Graham,et al.  Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study☆ , 2017, NeuroImage: Clinical.

[20]  Bernhard Hemmer,et al.  Cortical pathology in multiple sclerosis detected by the T1/T2‐weighted ratio from routine magnetic resonance imaging , 2017, Annals of neurology.

[21]  J. Helpern,et al.  Diffusional Kurtosis Imaging of the Corticospinal Tract in Multiple Sclerosis: Association with Neurologic Disability , 2017, American Journal of Neuroradiology.

[22]  Nadim Joni Shah,et al.  Diffusion kurtosis metrics as biomarkers of microstructural development: A comparative study of a group of children and a group of adults , 2017, NeuroImage.

[23]  E. Hui,et al.  Application of diffusional kurtosis imaging to detect occult brain damage in multiple sclerosis and neuromyelitis optica , 2016, NMR in biomedicine.

[24]  Siegfried Trattnig,et al.  Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging , 2016, Acta Neuropathologica.

[25]  Y Wang,et al.  Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation , 2016, American Journal of Neuroradiology.

[26]  S. Jespersen,et al.  Kurtosis fractional anisotropy, its contrast and estimation by proxy , 2016, Scientific Reports.

[27]  Wenzhen Zhu,et al.  Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation , 2015, Oncotarget.

[28]  Istvan Pirko,et al.  Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque , 2015, Annals of neurology.

[29]  M. F. Falangola,et al.  Diffusional Kurtosis and Diffusion Tensor Imaging Reveal Different Time-Sensitive Stroke-Induced Microstructural Changes , 2015, Stroke.

[30]  D. Reich,et al.  The formation of inflammatory demyelinated lesions in cerebral white matter , 2014, Annals of neurology.

[31]  Edward S Hui,et al.  Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone‐induced corpus callosum demyelination , 2014, NMR in biomedicine.

[32]  J. Parratt,et al.  Oligodendrocytes and the early multiple sclerosis lesion , 2012, Annals of neurology.

[33]  J. Helpern,et al.  Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[34]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[35]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[36]  C. Pozzilli,et al.  Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis , 1990, Neurology.

[37]  D. Reich,et al.  Multiple Sclerosis , 2018, The New England journal of medicine.

[38]  Hans Lassmann,et al.  An updated histological classification system for multiple sclerosis lesions , 2016, Acta Neuropathologica.